Novel Emboli Protection System during Cardiac Surgery: A Multi-Center, Randomized, Clinical Trial
The CardioGard cannula is safe and efficient in use during open-heart surgery
World's Largest Resource for Cardiovascular Perfusion
The CardioGard cannula is safe and efficient in use during open-heart surgery
The results of this study suggest that the use of autologous blood cell transfusion is safe and effective for patients with obstetric haemorrhage. Trial registration: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional and/or National Research Committee of Beijing Obstetrics and Gynecology Hospital, Capital Medical University (2016-XJS-003-01) as well as the 1964 Helsinki Declaration and its later amendments or other comparable ethical standards. The clinical trials were registered (ChiCTR-ICC-15,007,096) on September 28, 2015.
Normoxic cardiopulmonary bypass is associated with reduced myocardial oxidative stress compared to hyperoxic cardiopulmonary bypass in adult coronary artery bypass patients.